Loss-of-function genetic screens with pooled sgRNA and shRNA libraries aid in discovery / prioritization of drug targets, understanding of disease progression and gene-disease associations, analysis of signal transduction pathways, characterization of the mechanisms for compounds, uncovering of synergistic gene interactions, and identification of markers of drug resistance and sensitivity. This webinar presents a comparison of loss-of-function genetic screens performed with CRISPR versus RNAi technology.
Recommended Videos
Combating Infectious Diseases with Next-generation Sequencing
VideoLearn how next-gen sequencing is accelerating the process of diagnosing mysterious infectious diseases and helping doctors to deliver life-saving treatments.
WATCH NOWThermo Scientific™ NanoDrop™ One Microvolume UV-Vis spectrophotometer
VideoQuantify and qualify DNA, RNA, and protein samples with only 1-2 µL and have full-spectral data in seconds using the Thermo Scientific™ NanoDrop™ One Microvolume UV-Vis spectrophotometer.
WATCH NOWMicroCal PEAQ-ITC: The gold standard for measuring binding affinities
VideoThis video describes the 4 main reasons why MicroCal PEAQ-ITC is the ideal instrument for measuring binding affinities.
WATCH NOWComments | 0 ADD COMMENT
Like what you just watched? You can find similar content on the communities below.
Drug Discovery Genomics Research Proteomics & MetabolomicsTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
Login
You must be logged in to post a comment.